05 Nov TravelBug Health Explains Why Adults Need Travel Vaccines and a Pre-Trip Consult
Health Notice: Travel vaccines and prescription medications for malaria, travelers' diarrhea and altitude sickness should only be given or prescribed by a qualified healthcare provider after reviewing your health history and itinerary. Live vaccines, including yellow fever and oral typhoid, may not be appropriate if you are pregnant, breastfeeding, over 60 or have a weakened immune system. If you develop a fever during travel or in the year after visiting an area with malaria, seek medical care promptly and tell the provider where you traveled.
Editorial Notice: This article is general information and is not specific medical advice. Clinic details reflect how the practice describes its own services. Providers named or linked in this article are not warranted or endorsed by MedicalResearch.com or Eminent Domains Inc.
In late 2026, as holiday travel planning picks up, many adults are booking trips to regions where the health risks look nothing like those at home. TravelBug Health is a locally owned travel medicine clinic in Scottsdale, Arizona, offering pre-travel consultations, travel vaccinations and yellow fever certification from its single clinic.
This Q&A explains why a vaccine review and a pre-trip consult matter for adult travelers.
Dr. Freedman M.D.[/caption]
David O. Freedman, M.D.
Professor Emeritus of Infectious Diseases
Editor of the Textbook of Travel Medicine
World Health Organization—Member, Emergency Committee on Zika Virus
University of Alabama, Birmingham USA
MedicalResearch.com: What is the background for this outbreak?
Response: India has reported 2 confirmed (PCR and ELISA) Nipah virus (NiV) cases in West Bengal State where the Kolkata megalopolis is located; the state borders Bangladesh. Symptom onset in both cases was late December 2025 in 2 health care workers. One patient has improved while the other remains in the ICU. All samples from 200 contact persons tested negative for NiV. No further confirmed cases have been detected in West Bengal
Bangladesh has reported 1 confirmed NiV case in Rajshahi Division which neighbors India. Symptom onset was January 21, 2026, and the patient expired on January 28. The patient reported no travel history but reported repeated consumption of raw date palm sap between 5 and 20 January. All 35 contact-persons are being monitored and have tested negative for NiV and no further cases have been detected to date.
Dr. Anderson[/caption]
Dr. Weston B Anderson PhD
Postdoctoral Reasearch Scientist
International Research Institute for Climate and Society
The Earth Institute
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: We find that while drought continues to be a consistent trigger of food crises in Sub-Saharan Africa, protracted conflict has become relatively more important over the last decade.
We furthermore find that pastoral livelihoods have taken longer to return to food secure conditions following droughts as compared to agricultural livelihoods.
Dr. Kooraki[/caption]
Soheil Kooraki MSR MS, MD
on behalf of Dr. Ali Gholamrezanezhad MD and co-authors
Department of Radiological Sciences,
David Geffen School of Medicine, University of California at Los Angeles
Los Angeles, California
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: COVID19 is a novel strain of the coronavirus family causing pneumonia. Two similar strains were discovered in 2003 and 2012 to cause the so-called SARS and MERS outbreaks, respectively. Radiologists need to be prepared for the escalating incidence of COVID-19. We reviewed the literature to extract the epidemiologic and imaging features of SARS and MERS in comparison with known imaging features of COVID-19 pneumonia to have a better understanding of the imaging features of the COVID19 pneumonia in acute and post-recovery stages.

Dr. Emily Parker Hyle[/caption]
Emily Parker Hyle, M.D.
Assistant Professor of Medicine
Massachusetts General Hospital
MedicalResearch.com: What is the background for this study?
Response: We found that many children who were planning to travel internationally were eligible for MMR vaccination prior to departure but often did not receive it - especially if they were aged 6 months to 6 years. That is because most children do not routinely receive their first dose of MMR till 12-15 months of age and their second dose of MMR till 4-6 years of age. However, ACIP recommendations are different for children who are traveling internationally. The risk of being infected with measles is much higher outside of the US, so it is recommended that children older than 1 year have had 2 MMR vaccinations and that children 6-12 months receive 1 MMR vaccination prior to travel. MMR vaccination is a safe and effective way to greatly reduce the risk of measles infection.



